Cary J. Claiborne - 02 Nov 2021 Form 3 Insider Report for ADIAL PHARMACEUTICALS, INC. (ADIL)

Role
Director
Signature
/s/ Cary J. Claiborne
Issuer symbol
ADIL
Transactions as of
02 Nov 2021
Net transactions value
$0
Form type
3
Filing time
03 Nov 2021, 16:34:18 UTC
Next filing
08 Dec 2021

No securities are beneficially owned.